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          Mycobacterium tuberculosis   and   Salmonella   spp. 
have exploited their ability to grow intracellu-
larly to avoid recognition and killing by circu-
lating antibodies and the complement system. 
Thus, the main protective response toward in-
tracellular bacteria is provided by cell-mediated 
immunity; soon after infection, a strong infl  am-
matory reaction aimed at the containment and 
killing of the pathogens is initiated at the site of 
infection. The most complex examples of these 
structures are lung granulomas induced in re-
sponse to   M. tuberculosis   (  1  ). Diff  erentiated mac-
rophages, lymphocytes, and other immune cells 
are the main constituents of granulomas (  2, 3  ). 
During chronic infl  ammatory reactions, activated 
macrophages undergo functional modifi  cations, 
like the increase of cytoplasmic organelle num-
bers, and morphological transformation acquiring 
an epithelioid phenotype. Frequently, macro-
phages can fuse one with another to generate 
multinucleated giant cells with a high phago-
cytic potential. At early stages of infection, gran-
ulomas ensure mycobacterial containment, but 
at late stages, they can be exploited by the bac-
teria to hide and grow within the host. In this 
environment, the tubercle bacilli can survive 
for the lifetime of the host (  4  ). Eventual break-
down of granulomas caused by tissue pathology 
can lead to the promotion of transmission of a 
high burden of bacilli to susceptible hosts. Thus, 
granuloma formation can be benefi  cial to the 
host, but also to the tubercle bacilli facilitating 
their spreading and pathology (  4  ). 
  Granulomatous reactions have also been de-
scribed in the spleens and liver in response to 
  Salmonella   spp., both in mice and humans (  5  –  7  ). 
Whereas a functional adaptive immune response 
is required for the maintenance of the granu-
loma in response to   M. tuberculosis   (  2, 3  ), the 
same is not true in response to   S. typhimurium  , 
where CD4 and CD8 T cells are not required 
(  7  ). Soluble infl  ammatory mediators (TNF-    , 
IFN-    , IL-18, and IL-12) are instead essential 
for   S. typhimurium    –  induced granuloma forma-
tion, suggesting that the innate immune response 
plays a primary role (  8  –  10  ). In our previous 
study, we showed that intradermal injection of 
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  The role of matricellular proteins in bacterial containment and in the induction of patho-
gen-specifi  c adaptive immune responses is unknown. We studied the function of the matri-
cellular protein secreted protein, acidic and rich in cysteine (SPARC/osteonectin) in the 
dissemination of locally injected   Salmonella typhimurium   and in the subsequent immune 
response. We show that SPARC was required for the development of organized acute in-
fl  ammatory reactions with granuloma-like (GL) features and for the control of bacterial 
spreading to draining lymph nodes (DLNs). However, SPARC-related GL also inhibited 
dendritic cell (DC) migration to the DLNs and limited the development of adaptive immune 
response, thus conferring increased susceptibility to the pathogen. In SPARC-defi  cient 
mice, both DC migration and antigen-specifi  c responses were restored against bacteria, 
leading to protective anti  –    S. typhimurium   immunity. This highlights a new function of 
matricellular proteins in bacterial infection and suggests that initial containment of 
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infl  ammatory response in the skin that is reminiscent of a gran-
ulomatous reaction that blocks the migration of DCs, as well 
as of bacteria from the site of injection (  11  ). This system would 
give us the unique opportunity to analyze factors or molecules 
involved in organized infl  ammatory structures and  S. typhimurium   
containment after the dissemination of bacteria from the de-
fi  ned site of injection. An oral or an intravenous injection would 
lead to diff  used spreading of the bacteria and would not allow 
us to follow their path in a precise way; an intradermal ear 
injection, on the contrary, allows us to follow bacterial dis-
semination to a single DLN. The fi  rst question that we asked 
was whether the matricellular protein SPARC played any 
role in the development of bacteria-induced GLRs. SPARC-
defi  cient and control WT mice were injected in the ear pinna 
with 10  7   CFU of attenuated   S. typhimurium   SL3261 AT. This 
strain is defi  cient in the AroA gene and is dependent on 
p-aminobenzoic acid and 2,3-dihydroxybenzoate for synthesis 
of aromatic amino acids and growth. The availability of these 
compounds is limited in mammalian cells, thus restricting the 
growth of the bacteria (  26  ). At diff  erent times, animals were 
killed, and ears were snap frozen in optimal cutting com-
pound (OCT), sectioned, and stained with various markers to 
investigate the structure and the composition of the infi  ltrate. 
  To be sure that the analyzed sections were eff  ectively 
representative of the site of infl  ammation, a minimal dose of 
FITC-conjugated inert microbeads was coinjected with bac-
teria, and each slide was examined under the fl  uorescent 
microscope for the presence of emitting particles. Immuno-
histochemical decoration at day 5 after infection showed a 
clearly defi  ned, compact organized structure in the infi  ltrate 
of SPARC  +/+   ears; it was particularly rich in CD45  +   leuko-
cytes and surrounded by a ring of Cd11b  +   cells, reminiscent 
of a granulomatous reaction, even though a fi  brotic capsule 
was not observed, but this was expected for a primary reaction 
(  Fig. 1  ).   In contrast, the same markers in SPARC-defi  cient 
mice revealed a massive unorganized infi  ltrate (  Figs. 1 and 2  ).   
Further staining with anti  –    S. typhimurium   antibody showed 
that bacteria were, for the most part (but not totally) con-
tained within the GLR in wt mice, whereas they were spread 
in a wider area of infl  ammation in SPARC      /      ears (  Fig. 1  ). 
The absence of GLR in KO mice corresponded to irregular 
deposition of collagen IV that, by failing to encapsulate the in-
fl  amed area, lead to a more dispersed leukocyte infi  ltrate, as 
assessed by immunohistochemical staining (  Fig. 2  ) and by 
Masson trichromic stain of the infl  amed area (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20071734/DC1). 
This suggests that SPARC is involved in the formation of an 
organized infl  ammatory structure with features of a granu-
loma, likely via the deposition of collagen fi  bers. 
  The composition of the leukocyte infi  ltrate is comparable 
in SPARC      /      and   +/+   mice 
  We considered the possibility that the observed structural dif-
ferences of the infl  amed site could be caused by an altered 
pattern of infi  ltrating cells in SPARC-defi  cient mice as com-
pared with WT animals, which, for some reason, could be 
  S. typhimurium   leads to the generation of an acute infl  amma-
tory reaction, which is consistent with a granuloma-like reac-
tion (GLR) at the site of infection caused by the recruitment of 
infl  ammatory cells (  11  ). This blocks the migration of DCs to 
the draining LN (DLN) and the subsequent generation of an 
adaptive immune response. 
  A characteristic of granulomatous disorders is the increased 
deposition of several extracellular matrix (ECM) proteins (  12  ), 
but the role of the ECM in pathogen-induced granulomatous 
reactions still remains to be elucidated. Functional studies of 
unspecifi  c inhibition of matrix metalloproteinase (MMP) have 
shown that MMP plays a role in facilitating dissemination of 
  M. tuberculosis  , likely via ECM degradation (  13  ), suggesting a 
possible role for ECM in forming physical containment of the 
bacteria. The ECM is involved in tissue scaff  olding and re-
modeling, as well as cell migration, proliferation, and diff  er-
entiation. The ECM is composed of several structural proteins, 
growth factors, proteoglycans, and matricellular proteins. The 
latter is a growing family that comprises tenascin C, which 
accumulates in granulomas of the lung (  14  ); thrombospondin 1 
(TSP1) and TSP2; osteopontin; and secreted protein, acidic 
and rich in cysteine (SPARC/osteonectin). SPARC is evolu-
tionarily highly conserved and participates in numerous physi-
ological processes (  15  ). It is involved in bone mineralization 
(  16  ), cell proliferation and migration (  17  –  20  ), tissue remodel-
ing (  21  ), and angiogenesis (  22  ). SPARC-defi  cient mice have 
50% less collagen deposition (  23  ), which correlates with in-
creased DC migration (  24  ). After enhanced DC migration, 
the induction of a delayed type hypersensitivity and cutaneous 
contact hypersensitivity are faster because of a less structured 
ECM (  24  ). Further, upon skin injury, SPARC is increased in 
the skin (  23  ). Because massive collagen deposition is crucial at 
the onset of granulomatous infl  ammatory reaction (  25  ), we 
sought to fi  nd out whether SPARC-defi  cient mice had de-
fects in the development of granulomatous reactions and in 
the initiation of immune response to intracellular bacteria. 
  In this article, we have characterized the formation of a GL 
acute infl  ammatory reaction in response to intradermal injec-
tion of   S. typhimurium   in SPARC-defi  cient and -suffi   cient mice. 
In the absence of SPARC, mice failed to develop an orga-
nized GL reaction in response to   S. typhimurium  , leading to 
an accelerated spreading of the bacteria to the DLN and an 
increased immune response to   S. typhimurium  . However, this 
correlated with decreased systemic spreading of  S. typhimurium   
and conferred higher resistance to the pathogens. These fi  ndings 
highlight a new function of matricellular proteins in bacterial 
infection and suggest that initial containment of bacteria could 
be detrimental to the host by limiting the induction of adap-
tive immune responses. 
    RESULTS   
  SPARC      /      mice do not develop organized GL reactions 
  I.v. injection of   S. typhimurium   in mice induces the genera-
tion of granulomas in the liver that are aimed at bacterial 
containment (  8  ). We recently showed that intradermal (i.d.) 
  S. typhimurium   injection also leads to the induction of an acute JEM VOL. 205, March 17, 2008 
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  No relevant discrepancies were outlined in the infl  ammation 
pattern, neither in the recruitment of cell populations nor in the 
kinetic of the recruitment itself, except for the macroscopic gran-
ulomatous formation that was detectable only in WT controls. 
  The absence of organized infl  ammatory reaction correlates 
with endogenous DC migration from infected site 
  Generation of specifi  c immune response consequent to in-
fl  ammation normally requires DC migration from the periph-
ery to DLNs. Nevertheless, we have previously demonstrated 
that subcutaneous injection of bacteria blocks DC migration 
from the site of infl  ammation to DLNs (  11  ). We observed that 
impairment of granuloma formation in SPARC-defi  cient 
mice is associated with a restored capability of DCs to reach 
noncompatible with granuloma generation. Thus, we analyzed 
by fl  ow cytometry the infi  ltrate composition over time after 
  S. typhimurium   injection. WT and SPARC-defi  cient mice were 
injected i.d. with bacteria, the infl  amed area was excised, and 
constituent cells were analyzed at 48 and 72 h (  Fig. 3  ).   In 
these experiments, fl  uorescent beads were coinjected with 
bacteria to spot unequivocally the site of infl  ammation. 
  In both strains, F4/80 and Gr1  +   cells represented the most 
abundant cell populations, both in frequency and absolute 
numbers. At these time points, Gr1  +   cells are likely to corre-
sponded to infl  ammatory monocytes, as they were also positive 
for MHC class II (IA/IE). Lymphocytes and DCs were present 
in very low percentages and numbers, the latter ranging from 
1 to 6% without signifi  cant diff  erences between strains and time. 
    Figure 1.     SPARC      /      mice fail to develop an organized acute infl  ammatory reaction in response to   S. typhimurium  .  SPARC +/+   (right)  and 
SPARC     /     (left) mice were injected in the ear pinna with 10  7   CFU of attenuated   S. typhimurium   SL3261 AT. Immunohistochemical staining with anti-CD45 
(top), anti-CD11b (middle), and anti  –    S. typhimurium   (bottom) are shown on ear sections from mice killed 5 d after infection (brown stainings). Nuclei are 
stained in blue (hematoxylin). Images were merged by Photoshop to obtain whole ear sections. Original magnifi  cation of ear reconstructions was 5  ×  , and 
of enlarged areas was 20  ×  . Sections are representative of three independent experiments on four mice per group. Bar, 100    m.   
    Figure 2.     Collagen IV staining reveals disorganized collagen deposition and more scattered infi  ltrate in SPARC      /      mice.  SPARC +/+   (top  row) 
and SPARC     /     (bottom row) mice were injected in the skin with 10  7   CFU of attenuated   S. typhimurium   SL3261 AT. Immunohistochemical staining with 
anti  –  collagen IV (brown) and counterstaining of nuclei with hematoxylin (blue) is shown on sections from mice killed 5 d after infection. Numbers 
show the original magnifi  cation of the sections. Boxes represent the magnifi  ed areas in the adjacent right images. Bars: (left) 50     m; (middle) 25    m; 
(right) 5    m.   660 SPARC-RELATED GRANULOMA AND IMMUNITY TO BACTERIA | Rotta et al.
presence of bacteria. The effi   ciency of latex  +   DC migration 
to DLNs after bacterial injection was dramatically and signifi  -
cantly higher in SPARC      /      than   +/+   mice (  Fig. 4 A  ). The 
presence of bacteria in KO mice decreased the effi   ciency of 
DC migration of only 20% versus 80% reduction observed in 
control WT animals. Also, when we analyzed the total numbers 
of migrating cells to the DLN, we found a striking diff  erence 
when latex beads were injected together with bacteria in 
SPARC      /      versus   +/+   mice (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20071734/DC1). As expected 
from our previous data, DCs in the SPARC      /      background 
migrated better than in the WT background (  24  ). We recently 
ruled out the possibility that latex beads acquired the ability 
to reach the DLN in the absence of cellular transport because 
of the less organized collagen deposition in SPARC KO mice 
(  24  ). Therefore, the latex  +   cells that we fi  nd in DLN repre-
sent cells migrating from the injection site. 
  These data suggest that SPARC is essential for the process 
of blocking DC migration from the   S. typhimurium    –  infected 
site into the DLN. 
  Tissue-derived, and not DC-derived, SPARC is responsible 
for block of DC migration 
  DCs express SPARC (  24  ), which could play a role in cell 
diff  erentiation and/or maturation; thus, to evaluate whether 
SPARC KO bacteria-treated DCs displayed a faster kinetic 
of maturation, and whether this was responsible for their ca-
pacity to migrate after bacterial injection, we tested their abil-
ity to mature in response to   S. typhimurium   or LPS. 
  BM-DCs were generated from WT and SPARC-defi  cient 
mice, and activated with   S. typhimurium   or LPS. At diff  erent 
time points, the expression of costimulatory molecules was 
evaluated by fl  ow cytometry. As shown, no diff  erences in terms 
of kinetics or intensity of activation were evidenced (  Fig. 4 B  ). 
This, together with our previous observation that DCs gener-
ated from the two strains displayed similar migratory properties 
in vitro (  24  ), suggested that the restored ability of DCs to mi-
grate from the injection site to the DLN was likely not depen-
dent on intrinsic diff  erences of the DC population. To test this 
hypothesis, we evaluated whether tissue- or DC-derived 
SPARC was important to block DC migration from the in-
fected site. We performed a double adoptive transfer experi-
ment. WT and KO mice received contemporarily contiguous 
i.d. injections of red and green latex-laden BM-DCs from WT 
and KO strains, respectively. DC transfers were performed 
in the presence or absence of   S. typhimurium   SL 3261AT. 
Regardless of the type of DCs injected, their migration was 
abolished in the presence of bacteria only when inoculated into 
WT recipients (  Fig. 4, C and D  ). This indicates that restored 
DC migration is caused by diff  erences in the extracellular envi-
ronment and not by diff  erent intrinsic properties of the cells. 
  Absence of GLR corresponds to an enhanced specifi  c 
immune response in SPARC      /      mice 
  In our previous studies, we showed that both DC and bacte-
ria spreading to DLNs was impaired in WT mice (  11  ). Thus, 
the DLN (  Fig. 4 A  ).   To monitor endogenous DC migration, 
FITC-conjugated latex beads were used as tracers (  27  ). Mice 
were injected in four diff  erent sites of the dorsal skin, drained 
either by the inguinal or brachial LNs, with 10  7   particles. In-
jections were performed in the presence or absence of 10  7   
bacterial CFU (SL 3261 AT), and migration of DCs carrying 
latex to DLNs was assessed. 3 d after injection, animals were 
killed, DLNs were collected and teased, and cells were re-
leased by treatment with collagenase. Cells were then stained 
for IA/IE or CD11c, and the entire population was acquired 
by fl  ow cytometry, to determine the absolute numbers of 
DCs carrying latex beads in DLNs. To evaluate the eff  ective 
role of bacteria on DC migration in the two strains, we eval-
uated the effi   ciency of DC migration expressed as the ratio of 
absolute numbers of DCs migrating in the absence versus the 
    Figure 3.     Infl  ammatory cell infi  ltrate composition is very similar 
in SPARC  +/+   and SPARC      /      mice.  SPARC +/+   and  SPARC    /     mice  were 
injected intradermally in the back skin with 10  7   CFU of attenuated  
S. typhimurium   SL3261 AT 48 and 72 h later, the sites characterized by 
an infl  ammatory reaction were excised, and cells were isolated by collagenase 
treatment. Cells were stained with fl  uorescent antibodies and analyzed 
by fl  ow cytometry. (A) Y axes show percentage of marker-positive cells, 
x axes show the analyzed markers. (B) Y axes show total numbers of marker 
positive cells, x axes show the analyzed markers. Error bars represent the 
SD of three independent mice. One of three independent experiments is 
shown. SPARC      /    , black bars; SPARC  +/+ ,  white  bars.   JEM VOL. 205, March 17, 2008 
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  The number of proliferating T cells was signifi  cantly higher 
in SPARC      /      mice treated with OVA-expressing recombi-
nant bacteria compared with SPARC  +/+   mice, indicating 
an effi   cient priming of antigen-specifi  c T cells. OVA-specifi  c T 
cells underwent fi  ve cycles of proliferation in SPARC      /      mice, 
and barely two cycles in WT mice (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20071734/DC1). As a 
control, SPARC  +/+   and       /      animals injected with recombi-
nant bacteria carrying the empty vector displayed no OVA-
specifi  c T cell proliferation. Together, these results indicate 
that in the absence of SPARC, bacteria can be recovered from 
the DLN, and this correlates with specifi  c T cell activation. 
  Induction of adaptive immune response protects SPARC      /      
mice from   S. typhimurium   infection 
  The presence of bacteria in DLNs could be interpreted both 
positively and negatively. On one hand, it could allow prim-
ing of   S. typhimurium    –  specifi  c T cells and, consequently, the 
generation of a specifi  c immune response. On the other 
hand, it could represent the fi  rst step of infection spreading. 
we evaluated whether paralleling DC migration there was an 
increase of bacterial colonies recovered from DLNs. We show 
that a signifi  cant increase in bacterial CFU was detected in 
the DLNs of i.d. injected SPARC      /      in respect to WT coun-
terparts (  Fig. 5 A  ).   Whether this is caused by bacteria reaching 
the DLN on their own or being carried by DCs is unknown; 
however, the low number of bacteria recovered in the whole 
DLN is more suggestive of a DC-mediated transport than a 
massive emigration of free bacteria from the injected site. 
  As we showed that in the absence of DC migration or bac-
teria recovery in the DLN the adaptive immune response to 
bacteria-associated antigens was also impaired (  11  ), we tested 
whether T cell activation to bacterial antigens was induced in 
SPARC      /      mice. Mice were transferred with CFSE-labeled 
OVA-specifi  c transgenic T cells (from DO11.10 strain). 24 h af-
ter transfer, recipient animals were injected i.d. with recombi-
nant bacteria expressing (SL-OVA) or not expressing (SL-pGEX) 
OVA (10  7   CFU in 4 diff  erent sites), and 3 d later proliferation of 
OVA-specifi  c T cells in DLNs was evaluated by fl  ow cytome-
try, as a reduction of CFSE fl  uorescence (  Fig. 5 B  ). 
    Figure 4.     DC migration from infected sites is inhibited by host-derived SPARC.   (A) Endogenous DC migration is restored in SPARC     /     mice. 
10  7   fl  uorescent latex (LX) microspheres/site were injected i.d. in mice in four different sites in the presence or absence of 10  7   CFU of   S. typhimurium .  Mice 
were killed at day 3 after treatment and the total number of IA/IE  +   cells carrying FITC-latex particles per DLNs was assessed after acquisition of the whole 
sample. The effi  ciency of latex  +   cell migration (the number of latex  +   cells in DLN of mice injected only with latex particles is considered as 100% of migra-
tion) to the DLNs is shown. The difference between effi  ciency of migration of latex  +   cells in the presence of bacteria (LX + BT) in SPARC  +/+   (white  bars) 
versus SPARC     /     (black bars) mice is highly signifi  cant (***, P   <   0.0001). This is one experiment representative of three each with three mice per group. 
(B) BM-DCs from SPARC  +/+   and  SPARC    /     display the same kinetic of activation in vitro. BM-DCs were generated in GM-CSF  –  conditioned medium and 
activated with bacteria at a multiplicity of infection of 10:1 or with 1   μ  g of LPS. Up-regulation of costimulatory molecules was evaluated by fl  ow cytom-
etry at the indicated time points. One of two similar experiments is shown. (C) DC migration is inhibited by host-derived SPARC. BM-DCs from SPARC  +/+  
and SPARC     /     were loaded with green and red latex beads (LX), respectively. Mice were injected i.d. with BM-DCs from both strains in the presence or 
absence of bacteria (BT), and cell migration to the DLNs was assessed 2 d after injection. (left) The mean total effi  ciency of migration   ±   the SD of six different 
mice/group is shown. The difference in DC migration effi  ciency in the recipient SPARC  +/+   mice in the presence of bacteria is not statistically signifi  cant 
(P   >   0.05). (right) Representative dot plots showing total migrated cells from single DLNs in the different conditions. Recipient line shows the recipient 
background where BM-DCs from the two donor strains were injected in the presence or absence of bacteria (BT). (top) Dot plots show the recovery of 
Red LX laden SPARC     /     BM-DCs; (bottom) dot plots show the recovery of Green LX laden SPARC  +/+   BM-DCs.   662 SPARC-RELATED GRANULOMA AND IMMUNITY TO BACTERIA | Rotta et al.
these doses, mice were similarly susceptible to   S. typhimurium   
infection. In contrast, at low dose (10  3   CFU of bacteria), SPARC 
KO animals were dramatically more resistant when challenged 
with   S. typhimurium  , as the majority of mice survived till day 22 
in the KO mice, whereas by day 11, all of the WT mice were 
dead. This indicates that even though SPARC      /      mice are im-
paired in their ability to form a GL structure, they do not display 
increased susceptibility to   S. typhimurium   infection; instead, at 
low doses they are more protected. 
  We hypothesized that the presence of a granuloma, by 
blocking the initiation of an adaptive immune response, was 
also impeding the control of the growth of   S. typhimurium   
escaping the skin granulomatous reaction. To test this hy-
pothesis, we evaluated whether the augmented survival of 
SPARC-defi  cient mice and the early presence of bacteria 
in DLNs, was associated with a retarded onset of systemic 
Therefore, we evaluated whether the aforementioned spe-
cifi  c response generated was suffi   cient to face spreading of in-
fection by assessing the lethality of mice after injection of 
increasing doses of virulent   S. typhimurium  . We fi  rst tested 
whether DC migration was also impaired after subcutaneous 
injection of virulent   S. typhimurium  , i.e., bacteria able to rep-
licate in vivo (SL1344). As shown in Fig. S4 (available at http://
www.jem.org/cgi/content/full/jem.20071734/DC1), both 
10  3   and 10  5   CFU of   S. typhimurium   inhibited DC migration 
to the DLN, a feature that was restored in SPARC      /      mice. 
  We then challenged SPARC      /      and   +/+   mice with increas-
ing doses of live, fully virulent   S. typhimurium  , ranging from 10  3   
to 10  7   CFU (  Fig. 6  ).   At higher doses of bacteria, both strains 
displayed an overimposable mortality rate, suggesting that, at 
    Figure 5.     Restored DC migration correlates with enhanced bacte-
rial counts into DLN and increased T cell proliferation.   (A)  Bacterial 
load in SPARC     /     is higher than that in SPARC  +/+   DLNs at days 2 and 3 
after injection. DLNs of mice treated with bacteria were lysed with Na 
deoxycholate and plated on LB agar. Bacterial CFU were counted after 
overnight incubation at 37  °  C. The difference between bacterial counts at 
48 and 72 h in DLN from SPARC  +/+   versus  SPARC    /     mice is highly signifi  -
cant (*, P   <   0.01; **, P   <   0.001). One of two similar experiments is shown. 
(B) OVA-expressing recombinant bacteria induce proliferation of OVA-
specifi  c CD4 T cells in SPARC     /    , but not in SPARC  +/+   mice. SPARC WT and 
KO recipient mice were adoptively transferred with 3   ×   10  6   CFSE  labeled 
DO11.10 CD4  +   T cells, and were injected i.d. 24 h later with recombinant 
  S. typhimurium    –  expressing (SL-OVA) or not expressing (SL-pGEX) OVA. 
Proliferation of transferred T cells in DLNs was assessed 3 d after  
S. typhimurium   injection. The number of CFSE  +   proliferating cells is shown 
  ±   the SD of 8 mice per group. The difference in T cell proliferation in 
SPARC  +/+   versus SPARC     /     mice is highly signifi  cant (***, P   <   0.001).     
    Figure 6.     SPARC      /      mice are more resistant to low dose intrader-
mally injected pathogenic   S. typhimurium  .   Different amounts of bac-
teria, ranging from 10  3   to  10 7   CFUs, were injected intradermally and 
mouse survival was analyzed. Kaplan-Meyer survival curves are shown. 
Whereas at 10  4   to  10 7   CFU there was no difference in survival curves, at 
10  3   CFU, the difference between SPARC  +/+   and  SPARC    /     mice was statis-
tically signifi  cant (P   <   0.01, Log-Rank). This is one representative of three 
different experiments, each performed with fi  ve mice per group.     JEM VOL. 205, March 17, 2008 
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  The sudden increase of bacteria in nondraining organs in 
WT animals at day 9 could suggest that within the granulo-
matous reaction,   S. typhimurium   grows undisturbed because of 
the inability to initiate a rapid anti  –    S. typhimurium   response 
until the bacterial burden is such to disrupt the granuloma 
structure. The massive colonization of distal nondraining organs 
by   S. typhimurium   could be suggestive of a nonlymphaticly 
mediated dissemination. 
  Subcutaneous vaccination is protective only 
in SPARC      /      mice 
  Thus, if early dissemination of   S. typhimurium   is required to 
induce a protective anti  –    S. typhimurium   response, we would 
then expect that only in SPARC      /      mice would a low dose 
of i.d. injected avirulent   S. typhimurium   vaccinate against the 
fully virulent strain. Both strains of animals were vaccinated 
with intradermal injection of 2   ×   10  3   CFU of attenuated   
S. typhimurium   SL3261 AT. 2 wk after immunization, mice were 
challenged i.v. with a lethal dose of virulent   S. typhimurium   
(10  3   CFU; SL1344), and survival was assessed. All SPARC  +/+   
infection in these animals, measured as colonization of non-
draining lymphoid organs. WT and KO mice received a single 
i.d. injection of 10  3   CFU of fully virulent and replicating 
  S. typhimurium  , and were killed at diff  erent time points. Bacterial 
outgrowth in DLN, nonDLNs, and the spleen was evaluated 
by plating serial dilution of lysed cells (  Fig. 7 A  ).   5 d after i.d. 
injection, colonies were found only in DLNs, with a signifi  cant 
diff  erence between SPARC  +/+   and SPARC      /      animals, the 
latter showing a 10-fold higher number of recovered CFUs. 
This pattern of DLN colonization was conserved up to 9 d 
after injection. Conversely, at this time, bacteria had massively 
invaded the spleen and the nonDLNs of SPARC  +/+   but not 
SPARC      /      mice, showing a 100-fold higher numbers in WT 
spleen and a 10-fold higher bacterial load in WT LNs versus 
the corresponding organs of SPARC-defi  cient animals. At day 
12, DLNs of both strains were equally colonized by pathogens, 
but, again, a signifi  cantly higher number of bacteria was still 
found in the LNs and spleen of WT compared with SPARC      /      
animals. The majority of WT mice did not survive day 12, 
making a comparison at later time points impossible. 
    Figure 7.     SPARC      /      mice display reduced systemic bacterial dissemination.   (A) Bacterial dissemination was evaluated in SPARC  +/+   and  SPARC    /    
animals injected intradermally with 10  3   CFU of pathogenic   S. typhimurium  . DLNs, nonDLNs, and spleens were lysed and plated at different time points. 
Total bacterial count/organ is shown   ±   the SD of 12 different mice per group. The difference in bacterial recovery in SPARC  +/+   and  SPARC    /     animals  is 
statistically signifi  cant (*, P   <   0.01). (B) Intradermal immunization with attenuated   S. typhimurium   can protect SPARC     /     but not SPARC  +/+   mice  from 
subsequent challenge with pathogenic   S. typhimurium .  SPARC +/+   and  SPARC    /     mice were vaccinated subcutaneously with 2   ×   10  3   CFU of attenuated  
S. typhimurium   or with PBS as a control. 2 wk after vaccination, all mice were challenged i.v. with 10  3   CFU of pathogenic   S. typhimurium  . Only SPARC-
defi  cient mice vaccinated with bacteria survive upon challenge with virulent   S. typhimurium  . Kaplan-Meyer survival curves are shown. This is one representa-
tive of four different experiments each performed on fi  ve mice per group. The difference between the SPARC     /    -vaccinated group versus all the others is 
statistically signifi  cant (P   <   0.01, Log-Rank).     664 SPARC-RELATED GRANULOMA AND IMMUNITY TO BACTERIA | Rotta et al.
  Guerin (  36  ) and are highly susceptible to   M. tuberculosis   infec-
tion (  37  ). However, TNF plays a major role in infl  ammatory 
responses and intracellular bacterial clearance by inducing 
macrophages to produce nitric oxide and chemokines (CCL2, 
CCL5, CCL9, and CXCL10) involved in the subsequent re-
cruitment of infl   ammatory cells (  38  ). TNF-defi  cient mice 
also show a defective homing of T cells that localize in the 
pulmonary perivascular and peribronchial region (  39  ). Thus, 
it is very diffi   cult to ascertain whether the observed increased 
susceptibility to bacterial infection in these mice is caused by 
the absence of a granuloma or to the lack of TNF-mediated 
antibacterial eff  ect. 
  In our model, fl  ow cytometric analysis of infl  ammatory 
cells from mice intradermally injected with   S. typhimurium   
reveals no diff  erences in terms of cell populations or cell num-
bers between SPARC WT and KO animals. However, the 
histochemical analysis of the injection site reveals that the in-
fl  ammatory reaction is not organized in SPARC      /      mice. 
This observation suggests that the absence of SPARC mainly 
aff  ects the structure and the organization of the infi  ltrate, rather 
than its composition, making this a very valuable model to 
study the role of acute infl  ammatory reactions in bacterial in-
fection. We observed, by means of immunohistochemical 
staining that most, but not all of the injected bacteria were 
confi  ned inside the GLRs in WT animals, whereas they were 
largely spread in KO counterparts. This correlated with an in-
creased spreading of   S. typhimurium   to DLN and to the ability 
of bacteria-laden DCs to reach the DLN. At later time points, 
we found that WT but not SPARC      /      mice had uncontrolled 
proliferation of bacteria in nonDLNs and were more suscep-
tible to  S. typhimurium   infection, suggesting that initial spread-
ing to DLNs is benefi  cial to control subsequent bacterial 
spreading. This correlated with the development of an anti  –
    S. typhimurium   response: injection of recombinant   S. typhimurium   
expressing OVA in mice adoptively transferred with DO11.10 
CD4 T cells revealed that in the absence of SPARC, OVA-
specifi  c T cells proliferated in DLNs, suggesting that a specifi  c 
response is mounted. Thus, whereas granulomatous reaction 
is actually eff  ective in an initial containment of bacteria, it is 
disadvantageous at later time points, as it also impedes the 
development of a protective immune response to the bacteria 
and their control after escape from the site of infection. Indeed, 
at low doses of bacteria, the ability of SPARC-defi  cient animals 
to mount a rapid and specifi  c immune response was benefi  -
cial, and resulted in an increased survival to pathogenic bacteria. 
Interestingly, at high doses of injected bacteria, both SPARC      /      
and   +/+   mice underwent rapid bacterial colonization and died. 
Two nonmutually exclusive possibilities could be envisaged: 
one in which the induced immune response can better control 
bacteria dissemination, and thus the absence of an organized 
granuloma in SPARC      /      mice does not impact on mouse 
survival; and another, in which the formation of a granuloma 
could also represent a favorable microenvironment for bacteria 
replication, protected from a possible secondary specifi  c im-
mune response (  4  ). The sudden dissemination of   S. typhimurium   
in WT animals between day 5 and 9 to nondraining organs 
mice, irrespective of vaccination, and nonvaccinated SPARC      /      
animals died between 6 and 15 d after injection (  Fig. 7 B  ). 
On the contrary, 75% of vaccinated SPARC-defi  cient mice 
survived the challenge. These results suggest that the i.d. 
route of administration is highly ineffi   cient for vaccination 
purposes, likely because of the inability of DCs to migrate 
to DLNs and to initiate pathogen-specific responses. In 
SPARC      /      mice where DCs can migrate to the DLN and 
initiate an antigen-specifi  c response, the i.d. route of admin-
istration allows us to generate protection toward virulent   
S. typhimurium  . This experiment also shows that the two strains 
of mice are equally susceptible to i.v. administration of   S. ty-
phimurium   (see nonvaccinated mice), indicating that the dif-
ferences observed in survival of mice challenged with 10  3   CFU 
of pathogens intradermally are not caused by strain-dependent 
intrinsic resistance to pathogens, but to skin-related diff  er-
ences that are presumably conferred by SPARC. 
  Altogether, these results suggest that although SPARC-
profi  cient mice control infection spreading at early time points, 
SPARC      /      mice display a much better outcome because of 
the initiation of a systemic response to bacterial antigens. 
    DISCUSSION   
  The role of the microenvironment in the control of the im-
mune function has recently been proposed (  28  –  32  ), suggest-
ing that the outcome of the immune response does not depend 
uniquely on the interaction between immune cells and anti-
gens. Rather, environmental tissues provide the immune sys-
tem with diff  erent signals that contribute to modulate its 
responses, according to specifi  c organ requirements. We used 
an already established skin infl  ammatory model to monitor the 
dissemination and spreading of locally injected   S. typhimurium   
and the subsequent immune response (  11  ). Our experimental 
model suggests that the requirement of the skin to contain 
pathogen dissemination overcomes the default   “  program  ”   of 
the immune system, which is to allow DC maturation and 
migration soon after pathogen encounter. This is achieved via 
tissue remodeling and the formation of an infl  ammatory reac-
tion reminiscent of a granuloma that limits the spreading of 
the bacteria, similar to what has been described in the lung in 
response to   M. tuberculosis   (  3, 4  ) or in the liver and spleen in 
response to oral   S. typhimurium   infection (  33  ). 
  We show here that a major player for the observed eff  ect 
is environmental SPARC. Matricellular protein SPARC par-
ticipates in numerous physiological processes, and SPARC-
defi  cient mice display an irregular and more lapsed deposition 
of collagen fi  bers (  34  ). We found that in response to   S. ty-
phimurium  , mice lacking SPARC have irregular collagen 
deposition and no signs of an organized infl  ammatory granu-
lomatous reaction, which is consistent with the notion that 
massive collagen deposition is required for the onset of gran-
ulomatous infl  ammatory reaction (  25  ). 
  It has been described that the absence of granuloma leads 
to an increased susceptibility of animals to pathogens (  35  ). Most 
of these studies were performed in TNF-defi  cient mice that 
fail to develop granulomas in response to Bacillus Calmette  –JEM VOL. 205, March 17, 2008 
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in parasite containment and whether persistence of   L. mono-
cytogenes   disrupts the ECM mesh in its own interest. 
  In conclusion, these results tell us that when the skin is ac-
cidentally injured, e.g., by a cut, and is exposed to environ-
mental microorganisms, the immune system responds with the 
induction of a vigorous innate response culminating with a 
granulomatous reaction that is aimed at microbial contain-
ment. This response, however, retards the establishment of an-
tibacterial-specifi  c responses and is ineffi   cient in controlling   
S. typhimurium    ’  s growth, thus favoring its dissemination. A possi-
ble therapeutic implication of these results is that during intra-
dermal bacterial vaccination, one might consider administering 
a molecule for ECM degradation to favor DC migration into 
the DLNs and the subsequent immune response. Notably, an 
old strategy to heighten vaccination to tuberculosis was to co-
administer hyaluronidase with Bacillus Calmette-Guerin (  47  ). 
    MATERIALS AND METHODS   
  Mice.     5  –  6-wk-old BALB/c mice were purchased from Harlan. DO11.10 
OVA-TCR transgenic T cells were provided by D. Lo (Scripps Research In-
stitute, La Jolla, CA). SPARC KO mice, originally on a mixed 129SV/
C57BL/6 background, were backcrossed for 12 generations with BALB/
cAnNCrl (Charles River Laboratories) to obtain congenic SPARC KO mice. 
All experiments were performed in accordance with the guidelines established 
in the Principles of Laboratory Animal Care (directive 86/609/EEC) and 
approved by the Italian Ministry of Health. 
  Antibodies and fl  ow cytometry.     The following monoclonal antibodies and 
matched isotypes controls were purchased from BD Biosciences: CD4 (L3T4), 
CD8a (Ly2), CD19, IA/IE, CD11b (Mac-1), CD11c (N418), CD45R (B220), 
Gr1 (Ly-6G). Rat anti  –  mouse F4/80 was obtained from Caltag Laboratories. 
Pure rabbit   S. typhimurium   antiserum was purchased from ViroStat. 
  Flow cytometry analysis was performed with a FACSCalibur (CellQuest 
software; BD Biosciences). 
  Bacterial strains and preparation for injections.     The   S. typhimurium   
derivative SL3261 AT is a metabolically defective   aroA   strain generated from 
the SL1344 WT according to the methodology described by Datsenko and 
Wanner (  48  ). A recombinant strain of SL3261 AT was generated expressing 
either the gene coding for GST-OVA fusion (SL-OVA) or with the GST 
alone (SL pGEX). 10  7   CFUs of SL-OVA express nearly 1   μ  g protein. Single 
colonies were grown overnight at 37  °  C in Luria broth (LB; Difco) and re-
started the next day at 1:10 of the original volume to reach an OD600 = 
0.35, which corresponds to 7   ×   10  8   CFU/ml. 
  Mice treatments, skin infl  ammation induction, and latex migration.   
  Mice were anesthetized i.p. with Avertin 2.5% and shaved at four sites of the 
dorsal skin, which were drained either by the inguinal or brachial LNs. 10  7   
CFUs of bacteria were diluted to a fi  nal volume of 10   μ  l PBS and injected 
i.d. using a Hamilton syringe (Thermo Fisher Scientifi  c). 10  7   FITC-conju-
gated latex particles of 1   μ  m in diameter (Polysciences) were injected as trac-
ers in the presence or absence of bacteria. Migration of IA/IE  +   or CD11c  +   
cells carrying latex to DLNs was assessed 3 d after treatment. At indicated times, 
mice were killed, DLNs were collected and teased, and cells were released 
by treatment with 0.25% collagenase at 37  °  C for 25 min (Collagenase D; 
Roche). Cells were stained for IA/IE or CD11c expression. For quantifi  cation, 
the entire population of DLN cells was acquired by cytofl  uorometry and ab-
solute numbers of CD11c  +   or IA/IE  +   cells carrying latex beads were deter-
mined per LN. The region of the skin corresponding to the site of injection, 
as identifi  ed by faint visual appearance of green latex beads, was separated 
and cells were released after collagenase treatment and stained for FACS 
would favor this hypothesis, suggesting that bacteria grow 
undisturbed in the GLR until the granuloma falls apart. The 
role of protective immune response initiated by DC migration 
to the DLN is supported by the fi  nding that i.d. injection 
with low doses of nonvirulent   S. typhimurium   lead to protective 
immunity to virulent   S. typhimurium   injected i.v. only in 
SPARC      /      and not   +/+   mice. As nonimmunized strains were 
both similarly susceptible to   S. typhimurium   injected i.v., we 
can rule out intrinsic diff  erences in the ability of SPARC      /      
mice to resist intradermal   S. typhimurium   injection. 
  After our previous study on the role of environmental 
SPARC in DC migration, we show here that ECM also plays 
a role in DC migration to DLNs during bacterial infection. 
This is likely caused by the formation of a physical block gen-
erated by SPARC-mediated collagen deposition. This fi  nding 
suggests that ECM can be an obstacle for DC exodus from 
the tissue, and is in agreement with the observation that ECM 
degradation by matrix metalloproteases is required for DC 
migration (  40  –  44  ). In the absence of SPARC, the more lapsed 
collagen deposition could create holes in the ECM, rendering it 
traversable by the DCs. Thus, the inability of DCs to migrate 
to DLNs for T cell activation, as well as the generation of an 
environment that is conducive to bacterial replication, could 
account for the observed increased susceptibility of WT mice 
to   S. typhimurium   infection. We cannot exclude that SPARC 
could also play a role in blocking the diff  erentiation of mon-
ocytes into DCs in the skin, as we showed that intradermal 
bacterial injection impedes DC diff  erentiation from mono-
cytes (  11  ). However, our adoptive transfer experiments using 
DCs from SPARC WT or KO mice revealed a direct eff  ect 
of environmental SPARC on fully diff  erentiated DCs, sug-
gesting that this eff  ect is already exerted on mature DCs. This 
is a very rapid event, as it occurs 1 d after infection, which is 
consistent with active tissue remodeling (  11  ). Notably, solu-
ble antigens released by   S. typhimurium  , such as fl  agellin, that 
do not require cellular transport to reach the DLN, rapidly 
induce an immune response (  45  ), thereby confi  rming  our 
previous data showing that the presence of   S. typhimurium   does 
not inhibit the presentation of soluble proteins (  11  ). It remains 
to be established whether highly expressed cell-associated anti-
gens can also fi  nd a preferential route of presentation, possibly 
via nearby recruited phagocytes that are not involved within 
the granulomatous reaction, but with a delayed kinetic (  45  ). 
Either way, it is striking that when bacteria cannot gain access to 
DLNs during infection in WT animals (  11, 45  ), establishment 
of a protective anti  –    S. typhimurium   response is also lacking. 
  Thus, our results suggest that during skin bacterial infec-
tion, two events occur: on one side, DC diff  erentiation from 
monocytes is impaired; and on the other side, already diff  er-
entiated DCs, as well as bacteria, are retained at the site of in-
fection by SPARC-dependent mechanisms. This feature does 
not seem to be unique to bacteria, as in response to   Leishmania 
monocytogenes   infection there is also a block of DC migration 
into the DLN during the fi  rst week of infection, which then 
resolves at later time points (  46  ). It would be interesting to 
evaluate whether in this case there is also SPARC involvement 666 SPARC-RELATED GRANULOMA AND IMMUNITY TO BACTERIA | Rotta et al.
were not normally distributed or by the Student  ’  s   t   test for continuous vari-
ables. Signifi  cance was defi  ned at P   <   0.05 (two-tailed test). Statistic calculations 
and Kaplan Meyer  ’  s curves were performed by JMP 5.1 software (SAS Cary). 
  Online supplemental materials.     Fig. S1 shows that diff  erent collagen or-
ganization characterizes the infl  ammatory reaction in the infected mouse 
skin of SPARC      /      mice. Fig. S2 shows that DC migration from infected 
sites is inhibited by host-derived SPARC. Fig. S3 shows that restored DC 
migration correlates with increased T cell proliferation. Fig. S4 shows that 
endogenous DC migration is also restored in SPARC      /      mice after injection 
of fully virulent   S. typhimurium  . A Supplemental materials and methods is also 
provided. The online version of this article is available at http://www.jem
.org/cgi/content/full/jem.20071734/DC1. 
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analysis as described in Antibodies and fl  ow cytometry. To visualize the in-
fl  ammatory granulomatous reaction, SPARC  +/+   and       /      mice were injected 
in the ear pinna or i.d. with 10  7   CFU of attenuated   S. typhimurium   SL3261 
AT, and mice were killed 5 d later. The specimens were immersed in OCT 
and snap-frozen in liquid nitrogen. 
  In vitro loading of DCs with latex microspheres and mouse treatment.   
  Murine DCs were generated from BM of SPARC  +/+   and       /      mice. In brief, 
BM was harvested by fl  ushing femurs with PBS. Cells were resuspended at 
2   ×   10  6   cells/ml in IMDM (Invitrogen) supplemented with 30% supernatant 
of GM-CSF expressing fi  broblasts. On day 6  –  8, the diff  erentiation of DCs 
was assessed by fl  ow cytometry using antibodies to CD11c, B7.2, CD40, 
H-2Kd, I-A/I-E. DCs were incubated with green-LX- or red-LX-micro-
spheres (1:100, DCs/microspheres) for 30 min at 37  °  C, and uptake of the 
LX-microspheres was determined by FACS analysis of CD11c-gated cells. 
3   ×   10  5   red-LX  –  loaded DCs from SPARC WT and 3   ×   10  5   green-LX  –  loaded 
DCs from SPARC KO mice (or vice versa) were injected intradermally in 
the dorsal skin of anesthetized SPARC WT and SPARC KO mice. Mice 
were killed 48 h after injection, DLNs were collected, and cells were ana-
lyzed by FACS. 
  TCR transgenic T cell adoptive transfer.     DO11.10 TCR-OVA T cells 
specifi  c for the OVA327  –  339 peptide in association with I-A  d  , were 
collected from spleen, brachial, and inguinal LNs. CD4  +   T cells were puri-
fi  ed by positive selection using anti-CD4 (L3T4) magnetic microbeads 
(Mini-MACS; Miltenyi Biotec), and cells were labeled with 5   μ  M carboxyl-
fl  uorescein-succinimidyl ester (CFSE) for 15 min at 37  °  C (Invitrogen). 
  SPARC  +/+   or       /      recipient mice were injected i.v. with 3   ×   10  6   
DO11.10 CFSE-labeled CD4 T cells and immunized with 10  7   CFUs of SL-
pOVA or SLpGEX (as a control) after 24 h. Mice injected with 10   μ  l of 0.25   μ  g 
OVA emulsifi  ed in CFA were always included in each experiment as a con-
trol. 3 d later, DLNs were collected and DO11.10 T cell proliferation was 
assessed as a reduction in CFSE labeling. 
  Bacterial outgrowth.     Cells from spleen, popliteal LNs, and DLNs (brachial 
or inguinal) of mice injected i.d. in the dorsal skin with 10  3   CFU of WT 
  S. typhimurium   (FB62, SL1344) were lysed with 0.5% sodium deoxycholate. 
CFUs were counted after serial dilution of cellular lysates on LB agar to quan-
tify the number of migrated live intracellular bacteria. 
  Immunohistochemistry.     For immunohistology, tissues were embedded 
in OCT, snap frozen in liquid nitrogen, and sectioned at 7   μ  m. Sections were 
subsequently fi  xed in acetone for 10 min, placed in 3% H  2  O  2  /MeOH solution 
for 5 min to block endogenous peroxidase activity, rinsed in PBS, and blocked 
in 10% FCS for 20 min. 
  Specimens were then incubated for 1 h with biotinylated primary anti-
bodies or with rabbit anti  –    S. typhimurium   antibody (ViroStat) or rabbit poly-
clonal antibody against mouse collagen type IV (AB756; Chemicon). After 
washing, sections were overlaid with avidin  –  peroxidase complex for 30 min 
(Sigma-Aldrich). Peroxidase-conjugated mouse anti  –  rabbit antibody (Dako-
Cytomation) was used as secondary antibody for sections incubated with anti  –
    S. typhimurium   and anti  –  collagen IV primary antibodies. Antigen was revealed 
with 3,3    -diaminobenzidine (Sigma-Aldrich) according to the manufacturer  ’  s 
instructions. Sections were counterstained with Mayer  ’  s hematoxylin, dehy-
drated in graded alcohol (70, 90, and 100% ethanol), and mounted in Eukitt 
mounting medium (Merck Eurolabs). All images were captured on a micro-
scope (Leica) equipped with a digital camera (DXM1200; Nikon), analyzed 
using ACT1 software, and merged by Photoshop (Adobe). 
  Mouse vaccinations and challenges.     Mice were injected intradermally in 
the dorsal skin with 2   ×   10  3   CFU of avirulent SL3261 AT. 2 wk later mice 
were challenged i.v. with a lethal dose of virulent   S. typhimurium   (10  3   CFU, 
SL1344), and survival was assessed. 
  Statistical analysis.     Statistical signifi  cance was evaluated by nonparametric 
Mann-Whitney   U   test (Wilcoxon-Kruskal Wallis) to analyze variables that JEM VOL. 205, March 17, 2008 
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